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Abstract
Background: The common marmoset monkey (Callithrix jacchus), a small non-endangered New World primate native
to eastern Brazil, is becoming increasingly used as a non-human primate model in biomedical research, drug development
and safety assessment. In contrast to the growing interest for the marmoset as an animal model, the molecular tools for
genetic analysis are extremely limited.
Results:  Here we report the development of the first marmoset-specific oligonucleotide microarray (EUMAMA)
containing probe sets targeting 1541 different marmoset transcripts expressed in hippocampus. These 1541 transcripts
represent a wide variety of different functional gene classes. Hybridisation of the marmoset microarray with labelled RNA
from hippocampus, cortex and a panel of 7 different peripheral tissues resulted in high detection rates of 85% in the
neuronal tissues and on average 70% in the non-neuronal tissues. The expression profiles of the 2 neuronal tissues,
hippocampus and cortex, were highly similar, as indicated by a correlation coefficient of 0.96. Several transcripts with a
tissue-specific pattern of expression were identified. Besides the marmoset microarray we have generated 3215 ESTs
derived from marmoset hippocampus, which have been annotated and submitted to GenBank [GenBank: EF214838 –
EF215447, EH380242 – EH382846].
Conclusion: We have generated the first marmoset-specific DNA microarray and demonstrated its use to characterise
large-scale gene expression profiles of hippocampus but also of other neuronal and non-neuronal tissues. In addition, we
have generated a large collection of ESTs of marmoset origin, which are now available in the public domain. These new
tools will facilitate molecular genetic research into this non-human primate animal model.
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Background
The common marmoset monkey (Callithrix jacchus), a
small non-endangered New World primate native to east-
ern Brazil, is becoming increasingly used as a non-human
primate model in biomedical research, drug development
and safety assessment. Not only their close genetic, phys-
iological and metabolic similarity to humans but also sev-
eral unique physiological differences between Old World
and New World primates, underlie its widespread use as
an animal model in studies involving aspects of infectious
disease, stem cell research, neural and cognitive sciences,
toxicology and drug development and reproductive biol-
ogy. Moreover, its availability, size, ease of breeding in
laboratory conditions and its clear advantages over other
non-human primates in terms of animal welfare, costs
and practicality contribute to its popularity as an attractive
alternative to other non-human primate species such as
the rhesus macaque [1]. In contrast to the growing interest
for the marmoset as an animal model, the molecular tools
for genetic analysis are extremely limited.
Although a Marmoset Genome Project was initiated in
2004 and is ongoing [2], today there are still only very few
mRNA sequences of marmoset origin available in the
public domain. To allow gene expression profiling of dif-
ferent marmoset organs and delineation of complex bio-
logical pathways, we have developed a marmoset-specific
DNA microarray, called EUMAMA (EUropean MArmoset
MicroArray) starting from large scale EST sequencing of
marmoset transcripts to generate the required sequence
information.
The marmoset array is an initiative within a European
Commission-funded consortium aimed at investigating
the long term effects of prenatal exposure to glucocorti-
coids [3] (hormones secreted by the adrenal cortex in
response to stress) in a non-human primate model. The
working hypothesis of this consortium is that excessive
foetal exposure to glucocorticoid hormones (GCs) exerts
organisational effects on the development of a variety of
target tissues resulting in altered gene expression patterns
that may persist throughout life. These 'programming'
effects are believed to shape vulnerability to a variety of
adult diseases including heart disease, diabetes, kidney
failure and brain disorders [4-8]. Since the effects of pre-
natal GC exposure are so widespread, we chose to initially
focus on the effects in the brain by using hippocampal
RNA as a source to generate EST sequences on the marmo-
set array. The hippocampus is a brain structure involved in
learning and memory processes, mood and regulation of
the stress response via the hypothalamic-pituitary-adrenal
axis. GCs are essential for normal hippocampal develop-
ment, exerting a wide spectrum of effects, resulting in
altered structural plasticity and function [9-12]. Therefore,
the obvious applicability of the marmoset microarray is to
study neuronal gene expression. However, we show here
that the microarray can also be used to generate expres-
sion profiles in a wide variety of non-neuronal marmoset
tissues.
Besides the marmoset microarray we have generated 3215
ESTs derived from marmoset hippocampus, which have
been functionally annotated and submitted to GenBank
[GenBank: EF214838 – EF215447, EH380242 –
EH382846]. These new tools will facilitate molecular
genetic research into this non-human primate animal
model.
Results
Mapping, annotation and submission of sequences to 
GenBank
A total of 3441 high quality sequences (Phred score:
Q15>600; 87.5% of the sequences also passed the thresh-
old of Q20>600 bp; the overall minimal Q20 score was
429 bp) were selected for annotation [13]. After removal
of redundant sequences, 3215 high quality unique 3' EST
sequences remained which were trimmed to an average
length of 678 bases. Annotation of the EST dataset to the
RefSeq dataset of human genes allowed unambiguous
assignment of gene names for 2250 sequences. A remain-
ing 292 sequences could also be confidently assigned with
gene names by mapping to the human genome or cross-
species mapping. Of these 2542 (2250 + 292) sequences
assigned with a gene name, 610 (19%) sequences could
also be annotated with an open reading frame (ORF) (Fig-
ure 1A). These ORF-containing sequences were submitted
to GenBank [GenBank: EF214838 – EF215447]. The
majority of the remaining 673 sequences without an
assigned gene name consisted of a group of 642 (20%)
which could not be matched to a known mRNA but were
mappable on the genome and 31 (1%) which could not
mapped to RefSeq genes nor to a mammalian genome
(Figure 1A). The latter 31 genes most likely represent
novel genes that may be uniquely expressed in the mar-
moset hippocampus. All 2605 (81%) EST sequences with-
out an ORF were submitted to dbEST [GenBank:
EH380242 – EH382846].
Gene selection and construction of the marmoset 
microarray
A subset of 1448 of the annotated 3'ESTs were selected by
the EUPEAH consortium to be represented on the marmo-
set array, supplemented with 68 marmoset cDNA
sequences available in GenBank. We selected the Gene-
Chip® CustomExpress® Array Program of Affymetrix for
design and manufacturing of the marmoset array (format
100–2187 containing approx. 1,600 gene sequences at 11
probe pairs per probe set). This choice was based on the
previous experience of Affymetrix working with consortia
to design specific dedicated arrays but also due to theBMC Genomics 2007, 8:190 http://www.biomedcentral.com/1471-2164/8/190
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advantages of standardisation of the hybridisation and
data extraction procedure. The sequence data was submit-
ted to the Affymetrix Chip Design Group and used to
design 11 perfect match and mismatch 25-mer oligonu-
cleotides per sequence according to the standard algo-
rithms used in Affymetrix commercially available
catalogue arrays. The most optimal probes sets per
sequence were selected for in situ synthesis on the mar-
moset array. Each unique transcript was represented by a
single probe set, except for 11 transcripts where there was
no obvious ideal probe set. In these 11 cases 2 different
probes sets were synthesized in situ representing different
nucleotides of the same transcript. As controls the stand-
ard Affymetrix control set present on all Affymetrix expres-
sion arrays, consisting of quality control and alignment
controls as well as target preparation and hybridisation
controls, was tiled. Since we did not have a set of full-
length housekeeping control genes of the marmoset for
assessment of sample quality, scaling and/or normaliza-
tion of arrays, the species-specific control sets of rhesus
monkey and human were tiled. In addition, both 5' and 3'
sequences of 11 marmoset genes abundantly expressed in
hippocampus were included as controls for assessing the
overall labeling efficiency and quality of biotin-labeled
target sample (Table 1).
The final design of the marmoset microarray consisted of
a total of 1649 probe sets of which 97 control probe sets
and 1552 probe sets representing 1541 different marmo-
set transcripts. A total of 71 probe sets were derived from
68 different sequences already available in GenBank,
while the remaining 1481 probe sets were derived from
1473 of our proprietary sequences obtained by sequenc-
ing marmoset ESTs. The majority (1445) of these 1473
ESTs were derived from the set of 3215 ESTs that have
been submitted to GenBank (Figure 1B). Another 28 ESTs
had already been selected for representation on the mar-
moset array based on our initial annotation, but did not
pass the criteria we applied for GenBank submission.
The majority of the ESTs represented on the marmoset
array assigned with a gene symbol (in total 1251) could
be classified according to gene ontology based on biolog-
ical function (1034) or molecular process (1106), repre-
senting a wide variety of different functional classes
(Additional file 1).
Expression profiling of hippocampus and several non-
neuronal tissues
Detection rates, indicated by present calls, on RNA
derived from hippocampus and cortex were high with
85% present calls. Even though the sequences represented
on the marmoset GeneChip are of hippocampal origin,
detection rates on RNA derived from various peripheral
tissues, including kidney, liver, adipose tissue, aorta, skel-
etal muscle, ovary and testis, were also high. All peripheral
tissues tested so far displayed approximately 70% present
calls, with the exception of adipose tissue that had an
overall level of detection of 78% (Table 2).
Correlation coeffcients were calculated based on hybridi-
sation signals on the marmoset microarray for all possible
combinations of tissues (Table 3). The highest correlation
coefficient (0.96) was obtained when comparing gene
expression in both neuronal tissues, i.e. hippocampus and
cortex, indicating a high degree of similarity in expression
profiles. In contrast, comparing hippocampal gene
expression to all peripheral tissues resulted in a severe
drop in correlation coefficient (Figure 2), ranging from
0.69 in muscle to 0.50 in liver.
Pie charts Figure 1
Pie charts. A: Composition of 3215 marmoset ESTs. 
Pie chart indicating the composition of the 3215 marmoset 
ESTs derived from a normalized hippocampal cDNA library. 
After mapping and annotation, a total of 1932 (60%) ESTs 
were assigned a gene name, 610 (19%) contained a partial 
ORF, 642 (20%) were mappable to a genome but could not 
be assigned a gene name and 31 (1%) could not be mapped. 
B: Origin of marmoset sequences. Pie chart indicating 
the origin of the marmoset sequences represented on the 
marmoset microarray. Of the in total 1541 marmoset tran-
scripts represented on the array the majority (1445 = 95%) 
were derived from the set of 3215 marmoset ESTs submitted 
to GenBank. The remaining 5% consisted of 68 pre-existing 
marmoset sequences already present in GenBank and 28 
ESTs from the hippocampal cDNA library that were not sub-
mitted to GenBank. The 1445 submitted ESTs could be sub-
divided into a group of 886 (58%) that were assigned a gene 
name, 364 (24%) with a (partial) ORF, 188 (12%) that were 
mappable but without a gene name or an ORF and 7 (0%) 
that were not mappable.
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Half of the probe sets of (767/1552 = 49.4%) were detect-
able (defined by a present call) in all tissues we tested so
far, albeit in most cases at varying levels. Sorting of the
expression profiles based on detection call allowed the
identification of transcripts expressed exclusively in 1 of
the 9 tissues tested. In liver, for example, we identified 7
probe sets with a present or marginal call that had absent
calls in the other 8 tissues tested. Three of these 7 probes
sets represented cytochrome p-450, enzymes that mediate
the oxidative biotransformation of most drugs and are
known to be predominantly expressed in liver [14]. Detec-
tion of 5 probe sets was restricted to the kidney, one of
which represented (prepro)renin. Renin is part of the
renin-angiotensin system known to play a major role in
volume regulation and is expressed at high levels in the
kidney [15]. Sperm protein 17 was exclusively expressed
in testis. An explanation for the fact that we find a number
of genes that appear to be exclusively expressed in other
tissues than brain, while the origin of the ESTs is brain tis-
sue, may be that these genes are predominantly derived
from the list of 68 pre-existing GenBank sequences on the
array, which are not necessarily expressed in brain.
Indeed, this appears to be the case in many instances. For
example, the 3 cytochrome p-450 probe sets exclusively
expressed in liver are derived from pre-existing GenBank
sequences, as well as 4 of the 5 kidney-specific probe sets
(including renin) and 3 of the 4 testis-specific probe sets
(including sperm protein 17). An additional explanation
is that expression levels in brain may be too low to detect
using microarrays, but were detectable in our normalised
cDNA library of hippocampus.
Detection of a total of 82 probe sets was restricted to neu-
ronal tissue (hippocampus and cortex) (Additional file 3).
Among these 82 probe sets were several ion channels
(KCNAB3, KCNF1, KCNH3, SCN1a, CACNB1), neuro-
transmitter receptors (GABRA5, 5-HTR2C, GRIN1), neural
cell adhesion molecules (NCAM, OPCML) and diverse
components involved in neurotransmitter secretion
(SYN2, SNPH), axonogenesis (SLITRK1) and neuro-
trophic factor signalling (NTRK2). It must be noted that
although the sequences have been annotated, the infor-
Table 2: Detection rates in different tissues on the marmoset 
array. The percentage present, marginal and absent calls 
obtained by hybridising the marmoset microarray with RNA 
from a panel of different tissues are indicated.
Tissue % present % marginal % absent
Hippocampus 84.8 0.9 14.3
Cortex 84.2 1.2 14.6
Fat 78.4 1.1 20.5
Aorta 70.6 1.7 27.6
Ovary 70.2 1.4 28.3
Liver 69.5 1.3 29.2
Muscle 69.4 1 29.6
Kidney 69.3 1.3 29.4
Testis 68.1 1.5 30.4
Table 1: Marmoset-specific controls on the array. An overview of the marmoset-specific controls present on the array. These controls 
represent transcripts abundantly expressed in hippocampus and probe sets from both the 3' and the 5' part of the transcript were 
selected for tiling on the array, as indicated by the probe set ID.
Probe Set ID Gene Symbol Gene Title
ACTB-5_at ACTB beta actin
ACTB-M_x_at ACTB beta actin
ADD1-3_at ADD1 adducin 1 (alpha)
ADD1-5_at ADD1 adducin 1 (alpha)
ALDH9A1-3_at ALDH9A1 aldehyde dehydrogenase 9 family, member A1
ALDH9A1-5_s_at ALDH9A1 aldehyde dehydrogenase 9 family, member A1
CAMK1G-3_at CAMK1G calcium calmodulin-dependent protein kinase IG
CAMK1G-5_at CAMK1G calcium calmodulin-dependent protein kinase IG
CCT8-3_at CCT8 chaperonin containing TCP1, subunit 8 (theta)
CCT8-5_s_at CCT8 chaperonin containing TCP1, subunit 8 (theta)
HDAC3-3_at HDAC3 histone deacetylase 3
HDAC3-5_s_at HDAC3 histone deacetylase 3
LPL-3_at LPL lipoprotein lipase
LPL-5_at LPL lipoprotein lipase
LRPAP1-3_at LRPAP1 low density lipoprotein receptor-related protein associated protein 1
LRPAP1-5_s_at LRPAP1 low density lipoprotein receptor-related protein associated protein 1
PLD3-3_x_at PLD3 phospholipase D3
PLD3-5_s_at PLD3 phospholipase D3
UBE2G2-3_at UBE2G2 ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)
UBE2G2-5_at UBE2G2 ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)
ZAK-3_s_at ZAK sterile alpha motif and leucine zipper containing kinase AZK
ZAK-5_s_at ZAK sterile alpha motif and leucine zipper containing kinase AZKBMC Genomics 2007, 8:190 http://www.biomedcentral.com/1471-2164/8/190
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mation is not that detailed that for each gene the exact iso-
form or splice variant is indicated. For example, a closer
look at the data of CACNB1 indicates that only isoform 1
is targeted by our sequence, which indeed is expressed in
brain, while isoform 2 is expressed in muscle. The users of
the marmoset microarray have access to the exact probe
set sequences as well as the EST sequences, allowing
unambiguous determination of which part of the tran-
script is targeted and which splice variants or isoforms are
detected.
Ninety probe sets were not detected in any of the tissues
tested, which may be an intrinsic property of the selected
probes or due to potential sequencing errors resulting in
mismatches of the probe sets with the labeled mRNA
(Additional file 3).
Discussion
We have constructed a marmoset-specific oligonucleotide
microarray representing 1541 different marmoset tran-
scripts expressed in hippocampus. Although the
sequences are primarily derived from a cDNA library of
hippocampus, we have demonstrated that the marmoset
array can also be efficiently used to characterise gene
expression in other tissues of non-neuronal origin. The
obtained detection rates are high, albeit somewhat lower
in peripheral tissues than in neuronal tissue. The repro-
ducibility of hybridisation is high, judged by the correla-
tion (0.957) between both neuronal expression profiles
(hippocampus and cortex). Moreover, the obtained tis-
sue-specific patterns of expression are in line with what
can be expected, with neuronal genes expressed exclu-
sively in hippocampus and cortex, cytochrome p-450s in
liver, preprorenin in kidney and sperm protein 17 in tes-
tis.
In the process of development of the marmoset micro-
array we have generated a set of 3215 marmoset 3' ESTs
which have been submitted to GenBank. The number of
marmoset sequences present today in publically available
sequence databases including GenBank are 1433 (query
"callithrix jacchus" at the National Center for Biotechnol-
ogy Information [16]), which is a mix of working draft
genomic sequence of the marmoset genome project, (par-
tial) mRNA sequences and ESTs and contains several
redundancies. Our contribution of 3215 different 3' ESTs
is a substantial expansion of the number of marmoset
sequences. Both the marmoset array and the generated
ESTs therefore significantly expand the available molecu-
lar tools for genetic analysis in this non-human primate
animal model.
To our knowledge EUMAMA is the first DNA microarray
specific for the common marmoset. As is the case with all
first-generation microarrays for a species, some day in the
future our marmoset microarray is likely to become obso-
lete and be replaced by an array targeting a larger part of
the transcriptome. Until there is a better replacement (e.g
when the marmoset genome is sequenced) this micro-
array is the only molecular tool allowing analysis of gene
expression of a reasonably comprehensive number of
genes expressed in marmoset brain. The strength of this
array is not only that it is species-specific, but also that
there are corresponding marmoset sequences available for
genetic follow-up of differentially expressed transcripts.
So far the availability of microarrays specific for non-
human primates is very limited. Oligonucleotide microar-
rays for the rhesus macaque (Macaca mulatta) have
recently become commercially available at both Affyme-
trix and Agilent [17]. However, today expression profiling
in non-human primates including chimpanzee (Pan trog-
lodytes), orangutan (Pongo pygmaeus), African green mon-
key (Chlorocebus aethiops), common marmoset (Callithrix
jacchus) and cynomolgus monkeys (Macaca fascicularis) is
still performed using human arrays [18-23], despite the
fact that sequence mismatches affect hybridisation inten-
sity and likely result in a high level of false negatives or
underrepresented expressed genes [18,24,25]. Interspecies
use of microarrays is particularly problematic when using
human microarrays to study gene expression in non-
Table 3: Comparison of gene expression between different tissues as determined by hybridisation of the marmoset array. The Pearson 
product moment correlation coefficient, r, is indicated for the expression profiles of all possible combinations of tissues from our tissue 
panel.
Hippocampus Cortex Fat Aorta Ovary Liver Muscle Kidney Testis
Hippocampus 1 0.95741 0.60714 0.56866 0.54152 0.50381 0.68915 0.54918 0.53917
Cortex 1 0.62146 0.58074 0.54732 0.51323 0.6862 0.74907 0.56225
Fat 1 0.8834 0.822 0.78857 0.7828 0.82475 0.68859
Aorta 1 0.81828 0.76857 0.78129 0.80429 0.67708
Ovary 1 0.76293 0.74486 0.80561 0.70452
Liver 1 0.7282 0.80027 0.65683
Muscle 1 0.74907 0.66837
Kidney 1 0.69856
Testis 1BMC Genomics 2007, 8:190 http://www.biomedcentral.com/1471-2164/8/190
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human primates that are more divergent to humans than
the great apes. While chimpanzee or orangutan have an
average nucleotide sequence divergence of 0.8–1% and
3% respectively [26-28], the average sequence divergence
of human and rhesus macaque is approximately 5%
[29,30] increasing to 11% when comparing the marmoset
and human genome [31]. A 4–8% difference in sequence
will cause each human-specific 25-mer probe on a micro-
array to contain on average a single nucleotide mismatch
with its target [32]. A large effect of sequence divergence
on hybridisation signal was found in a study using a
multi-primate cDNA array containing human, chimpan-
zee, orangutan and rhesus sequences, even between
organisms that are only diverged ~1% [24]. The general
picture that emerges is that the use of single species arrays
for comparison between species may be problematic and
yield spurious results [24], warranting careful data analy-
sis and a significant amount of confirmatory analysis
using other techniques. Meanwhile, the clear need for
generation of species-specific cDNA and oligonucleotide-
based microarray resources remains [32].
Conclusion
In summary, we have generated the first marmoset-spe-
cific DNA microarray and demonstrated its use to charac-
terise large scale gene expression profiles of hippocampus
but also of other neuronal and peripheral tissues. In addi-
tion, we have generated a large collection of ESTs of mar-
moset origin which are now available in the public
domain. These new tools will facilitate molecular genetic
research into this non-human primate animal model.
Methods
Generation of marmoset cDNA sequences
Total RNA was isolated from hippocampi of 5 adult mar-
mosets, both males and females ranging from 3 to 10
years in age, After checking the quality of the isolated RNA
it was pooled and used to construct a custom normalised
Scatterplots comparing expression profiles of different tissues Figure 2
Scatterplots comparing expression profiles of different tissues. Scatterplots of log10-transformed signal intensities of 
several tissue comparisons showing the similarity of the expression profiles as indicated by the correlation coefficient.
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cDNA library in pCMVSport6.1 (Invitrogen, Carlsbad,
USA). For the development of the marmoset microarray a
total of 23,300 clones were gridded in 61 384-well plates.
In total approximately 5700 sequencing reactions were
performed at Baseclear (Leiden, The Netherlands) using
an anchored oligo-dT primer on 15 randomly selected
384-well plates to generate partial 3' EST sequences.
RNA preparation and labelling
Total RNA was isolated using TRIzol® reagent (Invitrogen
Life Technologies, Carlsbad, CA, USA) according to the
manufacturer's instructions. After isolation, total RNA was
purified using the QIAGEN RNEasy®  Mini Kit RNA
Cleanup procedure (QIAGEN Inc., Valencia, CA, USA).
RNA quality was assessed with the LabChip® RNA 6000
Nano Assay on the 2100 Bioanalyzer (Agilent Technolo-
gies, Palo Alto, CA, USA). Per RNA sample, 5 μg was used
as input into the MessageAmp™ II-Biotin Enhanced Single
Round aRNA Amplification Kit (AM1791, Ambion, Aus-
tin, USA) according to the manufacturer's instructions.
Briefly, total RNA was converted to double-stranded
cDNA followed by in vitro transcription to synthesize
biotin-labeled aRNA. After purification the size distribu-
tion of the aRNA was checked with the LabChip® RNA
6000 Nano Assay on the 2100 Bioanalyzer (Agilent Tech-
nologies) and the quantity was assessed by small sample
spectophotometry on a Nanodrop ND-1000 Spectropho-
tometer (NanoDrop Technologies, Wilmington, Dela-
ware USA).
Hybridisations
The biotinylated aRNA was fragmented and 15 μg was
hybridised to marmoset arrays at the Leiden Genome
Technology Center (LGTC®), Leiden University, The Neth-
erlands, according to the manufacturer's recommenda-
tions (Affymetrix, Santa Clara, USA).
Data analysis
Affymetrix GeneChip® Operating Software (GCOS) was
used to estimate signal intensities plus signal reliabilities.
Data was median normalized in excel and subsequently
scatterplots were constructed and correlation coefficients
calculated using R version 2.2.0 [33]. Probe sets assigned
with a gene symbol were functionally classified according
to biological process and molecular function using
Netaffx Analysis Center [34].
Mapping and annotation of EST sequences
In order to obtain high-quality data the EST sequences
were trimmed before further analysis. At the 3' end, at
least 15% of each sequence was removed so that final
DNA fragment lengths were 700 bases. In addition, 20
bases from the 5' end of the EST sequences were trimmed.
For the annotation of the EST dataset, the sequences were
reverse complemented and compared to the RefSeq data-
set of human genes (NCBI Refseq build 36.1) using a
locally installed version of the Blat software [35]. Remain-
ing sequences that could not be unambiguously assigned
to a gene name were mapped to the human genome
sequence (NCBI Refseq assembly version 36.1) according
to the standard parameters of the software. ESTs with a hit
on the genome were annotated with the gene name of the
gene which is located at the respective chromosome
region. Ambiguities, e.g. if an EST sequence covered more
than one gene, were resolved manually. Finally, a Blat
search with increasing sensitivity parameters was per-
formed to map ESTs across species.
The annotation procedure described above allowed a reli-
able annotation of EST data even if sequencing errors
would cause frame-shifts in coding regions. In order to
annotate open reading frames (ORFs) associated with the
ESTs, ORFs with a length of at least 100 bases starting
from the 5' end of the reverse complementary sequences
were extracted. The translated amino acid sequences were
mapped against the human protein sequences from Uni-
Prot (Release 50 of May 2006, [36]) using Blat [35]. All
sequences without any hit on a protein sequence starting
at the first position ofthe 5' end where rejected. The
remaining candidate ORFs were first validated by a com-
parison of the gene names from the UniProt hits to the
gene names of the above determined RefSeq hits. To be
included as bona fide ORFs, the translated ORF sequences
had to fulfil an additional criterion. The length of the pep-
tide sequences derived from the ESTs had to cover at least
80% of the peptide sequence length which can be
expected from the corresponding part of the protein
sequence from UniProt.
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